AstraZeneca PLC Files 6-K Report

Ticker: AZN · Form: 6-K · Filed: Apr 1, 2025 · CIK: 901832

Astrazeneca PLC 6-K Filing Summary
FieldDetail
CompanyAstrazeneca PLC (AZN)
Form Type6-K
Filed DateApr 1, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, foreign-issuer, reporting-update

Related Tickers: AZN

TL;DR

AZN filed a 6-K, confirming 20-F reporting. Standard update.

AI Summary

AstraZeneca PLC filed a Form 6-K on April 1, 2025, reporting as a foreign issuer. The filing indicates that AstraZeneca is submitting its annual reports under Form 20-F. The company's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.

Why It Matters

This filing is a routine report for foreign issuers, confirming their reporting status and providing updated corporate information to the SEC and investors.

Risk Assessment

Risk Level: low — This is a routine administrative filing by a large, established company and does not contain material new financial or operational information.

Key Players & Entities

  • AstraZeneca PLC (company) — Filer of the report
  • 001-11960 (company) — SEC File Number
  • 1 Francis Crick Avenue (company) — Business and Mail Address
  • Cambridge Biomedical Campus (company) — Business and Mail Address
  • CB2 0AA (company) — Business and Mail Address Zip Code
  • United Kingdom (company) — Company Location
  • Form 20-F (company) — Annual Report Form
  • Form 6-K (company) — Report Type

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign issuers that provides information which the registrant makes or is required to make public pursuant to the laws of the registrant's country of origin or domicile, for distribution or publication within the United States, or files or is required to file with a stock exchange on which the registrant has securities listed.

What is AstraZeneca PLC's SEC File Number?

AstraZeneca PLC's SEC File Number is 001-11960.

Where are AstraZeneca PLC's principal executive offices located?

AstraZeneca PLC's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.

Does AstraZeneca PLC file its annual reports under Form 20-F or Form 40-F?

AstraZeneca PLC indicates it files its annual reports under cover of Form 20-F.

What is the filing date of this Form 6-K?

This Form 6-K was filed as of April 1, 2025.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 1, 2025 regarding ASTRAZENECA PLC (AZN).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.